![]() | |
Clinical data | |
---|---|
Trade names | Emrok O |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C22H26FN3O5 |
Molar mass | 431.464 g·mol−1 |
3D model ( JSmol) | |
| |
|
Alalevonadifloxacin (trade name Emrok O) is an antibiotic of the fluoroquinolone class. [1] It is a prodrug of levonadifloxacin with increased oral bioavailability. [2] In India, it is approved for the treatment of infections with Gram-positive bacteria. [3]
![]() | |
Clinical data | |
---|---|
Trade names | Emrok O |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C22H26FN3O5 |
Molar mass | 431.464 g·mol−1 |
3D model ( JSmol) | |
| |
|
Alalevonadifloxacin (trade name Emrok O) is an antibiotic of the fluoroquinolone class. [1] It is a prodrug of levonadifloxacin with increased oral bioavailability. [2] In India, it is approved for the treatment of infections with Gram-positive bacteria. [3]